Aurora, Colorado 80045


Purpose:

Frailty as an adjunct to preoperative assessment of neurosurgical patients has never been evaluated. This study aims to determine if frailty predicts neurosurgical complications in brain tumor patients and enhances current perioperative risk models.


Study summary:

Preoperative risk assessment is important, but inexact, in older patients because physiologic reserves are difficult to measure. This also makes an important difference related to brain tumor patients, who may be burdened with systemic disease, alterations in cognition, or affected by other comorbidities. When assessing quality of life for brain tumor patients, having a better predictor of postsurgical outcome would be beneficial in appropriately counseling these patients. Frailty is thought to estimate physiologic reserves, and its use has been found to predict postoperative complications, length of stay, and discharge to a skilled or assisted-living facility in neurosurgical patients. Frailty as an adjunct to preoperative assessment of neurosurgical patients has never been evaluated. This study aims to determine if frailty predicts neurosurgical complications in brain tumor patients and enhances current perioperative risk models.


Criteria:

Inclusion Criteria: - Adult - Ambulatory (able to walk) - Scheduled for neurosurgical resection of brain tumor Exclusion Criteria: - Parkinson disease - Previous stroke - Taking: carbidopa/levodopa, donepezil hydrochloride, or antidepressants


NCT ID:

NCT02530749


Primary Contact:

Principal Investigator
D. R. Ormond, MD
University of Colorado, Denver

Jennifer Maitlen, RN, BSN
Phone: 303-724-1995
Email: jennifer.maitlen@ucdenver.edu


Backup Contact:

Email: mary.wang@ucdenver.edu
Mary Wang, BS
Phone: 303-724-4136


Location Contact:

Aurora, Colorado 80045
United States

Jennifer Maitlen, RN BSN
Phone: 303-724-1995
Email: jennifer.maitlen@ucdenver.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.